Envision Scientific Profile
Key Indicators
- Authorised Capital ₹ 2.30 Cr
as on 15-11-2024
- Paid Up Capital ₹ 1.45 Cr
as on 15-11-2024
- Company Age 16 Year,
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 141.98 Cr
as on 15-11-2024
- Satisfied Charges ₹ 98.55 Cr
as on 15-11-2024
- Revenue 37.05%
(FY 2023)
- Profit 146.78%
(FY 2023)
- Ebitda 13.37%
(FY 2023)
- Net Worth 10.43%
(FY 2023)
- Total Assets 28.47%
(FY 2023)
About Envision Scientific
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.30 Cr and a paid-up capital of Rs 1.45 Cr.
The company currently has active open charges totaling ₹141.98 Cr. The company has closed loans amounting to ₹98.55 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ambrish Thakker, Nipulkumar Patel, Parth Doshi, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230GJ2008PTC055732
- Company No.
055732
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Dec 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Envision Scientific Private Limited offer?
Envision Scientific Private Limited offers a wide range of products and services, including Infusion Syringes & Supplies, Catheter, Scalpels, Needles & Scissors, Surgical Accessories.
Who are the key members and board of directors at Envision Scientific?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Manish Doshi | Managing Director | 28-Jun-2010 | Current |
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Parth Doshi | Director | 20-Sep-2018 | Current |
Ambrish Thakker | Nominee Director | 20-Sep-2018 | Current |
Nipulkumar Patel | Director | 23-May-2011 | Current |
Financial Performance of Envision Scientific.
Envision Scientific Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 37.05% increase. The company also saw a substantial improvement in profitability, with a 146.78% increase in profit. The company's net worth Soared by an impressive increase of 10.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Envision Scientific?
In 2023, Envision Scientific had a promoter holding of 36.15% and a public holding of 63.86%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Concept Medical Research Private LimitedActive 16 years
Nipulkumar Patel, Parth Doshi and 1 more are mutual person
- Magical Holding Private LimitedActive 1 year 3 months
Parth Doshi and Manish Doshi are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 23 Feb 2023 | ₹29.86 Cr | Open |
Others Creation Date: 25 Mar 2022 | ₹106.39 Cr | Open |
Axis Bank Limited Creation Date: 31 Jan 2022 | ₹5.00 Cr | Open |
How Many Employees Work at Envision Scientific?
Envision Scientific has a workforce of 349 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Envision Scientific, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Envision Scientific's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.